Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines

By F. Stacul, A. Molen, P. Reimer, J. Webb, H. Thomsen, S. Morcos, T. Almén, P. Aspelin, M. Bellin, O. Clément and 2 more. European Radiology, 2011

881 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Global vascular guidelines on the management of chronic limb-threatening ischemia (2019, background): “MRA has the potential to produce images that are comparable in quality to DSA images but without exposure to ionizing radiation or iodinated contrast material, making contrast-induced nephropathy extremely rare.(27-29,57,263-269,272-276) Time-resolved techniques can accurately image flow patterns, w”
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease (2016, background): “The iodinated contrast used in CTA confers risk of contrast-induced nephropathy and (rarely) severe allergic reaction (123,124); CTA uses ionizing radiation.”
Update on the treatment of type 2 diabetes mellitus. (2016, methodology): “The physician contemplating metformin treatment In accordance with recent guidelines [287] , patients with an eGFR 45 mL/min should stop metformin 48 h before contrast investigations, and restart 48 h after.”